活性蛋白
蛋白質(zhì)是由一條或多條氨基酸殘基的長(zhǎng)鏈組成的生物大分子。活性蛋白質(zhì)，顧名思義，就是一類有活性的蛋白質(zhì)，與之對(duì)應(yīng)的是無(wú)活性蛋白質(zhì)。蛋白質(zhì)的活性變化可能是由酸堿度和溫度等因素引起蛋白質(zhì)結(jié)構(gòu)破壞，或者由一些失活物質(zhì)引起的。
華美生物活性蛋白主要包括細(xì)胞因子、酶和激素等，大多數(shù)活性蛋白質(zhì)的純度高達(dá)97％以上，這些蛋白都經(jīng)過(guò)驗(yàn)證活性和低內(nèi)毒素檢測(cè)，以凍干粉末形式儲(chǔ)存。我司承諾所有活性蛋白均能保證如說(shuō)明書(shū)或官網(wǎng)產(chǎn)品詳情所示功能，若您購(gòu)買的產(chǎn)品與上述不符，請(qǐng)及時(shí)與我們的銷售人員聯(lián)系。
活性蛋白分類
產(chǎn)品優(yōu)勢(shì)
- 純度高：>97%
- 低內(nèi)毒素：由LAL檢測(cè)方法測(cè)得內(nèi)毒素含量低于1.0EU/μg
- 活性驗(yàn)證：蛋白生物活性高達(dá)1.0x109 IU/mg以上
- 統(tǒng)一發(fā)貨形式：凍干粉形式
- 標(biāo)簽類型：無(wú)標(biāo)簽
The cytotoxicity assay of TNF
The SDS-PAGE of Serine protease inhibitor A3N
- 無(wú)載體：凍干前溶解在PBS中，無(wú)BSA
- 無(wú)動(dòng)物組分.
- 貨期：廠家直發(fā)，有庫(kù)存。一般5-10內(nèi)可到貨
- 價(jià)格&規(guī)格：可提供多種規(guī)格，性價(jià)比高
- 每個(gè)指標(biāo)都有標(biāo)準(zhǔn)COA.
- 指標(biāo)數(shù)據(jù)完整.
| 產(chǎn)品名稱 | 貨號(hào) | 規(guī)格 |
|---|---|---|
| Recombinant Human Interleukin-13 (IL13) (Active) | CSB-AP004321HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-17A (IL17A) (Active) | CSB-AP004331HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-17A (IL17A) (Active) | CSB-AP004341HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-17 receptor A (IL17RA), partial (Active) | CSB-AP004351HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-22 (IL22), partial (Active) | CSB-AP004361HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-23 receptor (IL23R), partial (Active) | CSB-AP004371HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-2 (IL2) (Active) | CSB-AP004381HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-15 (IL15) (Active) | CSB-AP004391HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-4 (IL4) (Active) | CSB-AP004401HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-36 receptor antagonist protein (IL36RN) (Active) | CSB-AP004411HU | 1mg(1mg*1 or 500ug*2)/500μg/50μg/10μg |
| Recombinant Human Interleukin-36 alpha (IL36A) (Active) | CSB-AP004421HU | 1mg(1mg*1 or 500ug*2)/500μg/50μg/10μg |
| Recombinant Human Interleukin-37 (IL37), partial (Active) | CSB-AP004431HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-7 (IL7) (Active) | CSB-AP004441HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-20 receptor subunit alpha (IL20RA), partial (Active) | CSB-AP004451HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-17F (IL17F) (Active) | CSB-AP004461HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interferon lambda-3 (IFNL3) (Active) | CSB-AP004471HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-4 (IL4) (Active) | CSB-AP004481HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-7 (IL7) (Active) | CSB-AP004491HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-2 (IL2) (Active) | CSB-AP004501HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
| Recombinant Human Interleukin-4 (IL4) (Active) | CSB-AP004511HU | 1mg(1mg*1 or 500ug*2)/500ug/50ug/10ug |
